ARROWHEAD PHARMACEUTICALS, INC.: accounts_receivable
| Value | {"amount": 845000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2020-09-30) |
| Status | superseded |
| Entity | ARROWHEAD PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:45:36.806619+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/e1b14f56-5565-459b-8c63-a7d9ddbcbb07
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-21-004319 · Open the official SEC filing →Retrieved: 2026-08-19T08:45:36.806619+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000879407/accounts-receivable/2020-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/e1b14f56-5565-459b-8c63-a7d9ddbcbb07
History
- supersedes {"amount": 845673, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} (evidence 0001564590-20-054893)